BioAge Labs (BIOA) Free Cash Flow (2023 - 2026)
BioAge Labs (BIOA) posted Free Cash Flow of -$24.1 million for Q1 2026, up 15.13% sequentially from -$28.4 million in Q4 2025, and down 35.32% YoY from -$37.2 million in Q1 2025.
BioAge Labs (BIOA) Free Cash Flow (2023 - 2026) Analysis & Trends
BioAge Labs has reported Free Cash Flow for 4 years, with the latest figure at -$24.1 million in Q1 2026.
- Quarterly Free Cash Flow fell 35.32% year-over-year to -$24.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$88.6 million (down 64.5% YoY) and the FY2025 annual result came in at -$82.3 million, down 59.09% from the prior year.
- Free Cash Flow climbed to -$24.1 million in Q1 2026 per BIOA's latest filing, from -$28.4 million in the prior quarter.
- Over five years, Free Cash Flow peaked at -$5.0 million in Q4 2024 and troughed at -$28.4 million in Q4 2025.
- A 4-year average of -$16.7 million and a median of -$15.9 million in 2024 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2024 and 2025: Free Cash Flow soared 40.75% in 2024, then plunged 462.98% in 2025.
- Over 4 years, Free Cash Flow stood at -$8.5 million in 2023, then jumped by 40.75% to -$5.0 million in 2024, then slumped by 462.98% to -$28.4 million in 2025, then advanced by 15.13% to -$24.1 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$24.1 million, -$28.4 million, and -$16.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | BioAge Labs | 439.65 Mn | 439.65 Mn | -14.23 Mn | -19.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -19.59 Mn |
| Jun 30, 2026 | -19.59 Mn |
| Mar 31, 2026 | -24.07 Mn |
| Mar 31, 2026 | -24.07 Mn |
| Dec 31, 2025 | -28.36 Mn |
| Dec 31, 2025 | -28.36 Mn |
| Sep 30, 2025 | -16.07 Mn |
| Sep 30, 2025 | -16.07 Mn |
| Jun 30, 2025 | -20.13 Mn |
| Jun 30, 2025 | -20.13 Mn |
| Mar 31, 2025 | -17.79 Mn |
| Mar 31, 2025 | -17.79 Mn |
| Dec 31, 2024 | -5.04 Mn |
| Dec 31, 2024 | -5.04 Mn |
| Sep 30, 2024 | -15.24 Mn |
| Sep 30, 2024 | -15.24 Mn |
| Jun 30, 2024 | -15.82 Mn |
| Jun 30, 2024 | -15.82 Mn |
| Mar 31, 2024 | -15.67 Mn |
| Mar 31, 2024 | -15.67 Mn |